Dr. Timothy Clay
Medical Education
22 Scholarly works
0 Projects
HIGHLIGHTS
2021
Journal article
Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature.
DOI: 10.1177/20458940209538412020
Journal article
Management of neutropenic fever in a private hospital oncology unit
DOI: 10.1111/imj.144642020
Journal article
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
DOI: 10.1200/OP.20.002292020
Journal article
DOCTORS UNDERSTANDING OF CONSENT LAW.
DOI: 10.1111/imj.148732019
Journal article
MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With Pancreatic Acinar Cell Carcinoma
DOI: 10.1200/PO.19.001592019
Journal article
Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolism
DOI: 10.1111/imj.143432019
Journal article
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma.
DOI: 10.1136/bcr-2018-228363
RECENT SCHOLARLY WORKS
2018
Journal article
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine
DOI: 10.1186/s13063-018-3091-82018
Journal article
Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients
DOI: 10.1093/annonc/mdy424.0502018
Journal article
Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infection
DOI: 10.1097/CAD.00000000000006552018
Journal article
Inferior vena cava filters (IVCFs): a review of uses and application to international guidelines at a single Australian center; implications of venous thromboembolism associated with malignancy.
DOI: 10.1177/20458940187765052017
Journal article
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma
DOI: 10.1007/s12032-017-1031-12017
Journal article
Attitudes of patients and physicians on repeat biopsies for lung cancer
DOI: 10.1080/23809000.2017.13395572017
Thesis / Dissertation
Adenocarcinoma of the lung: an exploration of the relationships between histopathology, molecular pathology and inflammatory markers and their relationship to patient outcomes
2016
Journal article
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
DOI: 10.1016/j.pathol.2015.11.002